
---
title: 'CRO板块持续拉升，昭衍新药、凯莱英涨停'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=5840'
author: 36kr
comments: false
date: Tue, 15 Feb 2022 02:38:24 GMT
thumbnail: 'https://picsum.photos/400/300?random=5840'
---

<div>   
36氪获悉，CRO板块持续拉升，截至发稿，昭衍新药、凯莱英先后涨停，博腾股份涨超10%，诚达药业此前封板，九洲药业、美迪西、药明康德、康龙化成等大涨超7%。  
</div>
            